MCL1 and neoplasm: Further tumor tissue analysis showed that the positive staining of the proliferation marker Ki-67 is significantly less in the tumors from injection of MCL-1 knockdown cells, compared to the tumors from injection of shRNA control cells (Figure 7G-H).